We are not supporting this browser

Oncology hug
Oncology hug

Nutrition in Oncology

Cancer is a complex disease with patients becoming at high risk of malnutrition both as a consequence of their illness and its treatment1. Over 50% of cancer patients present with weight loss at diagnosis and, for many patients, nutritional status continues to deteriorate during and after treatment.2,3

 

Up to 80% of all cancer patients will be malnourished.4

Cancer related malnutrition is driven by a combined effect of reduced nutritional intake and metabolic changes5-7. These factors contribute to negative energy and protein balance leading to weight and muscle mass loss1.

Poor nutritional status in addition to weight and muscle mass loss can lead to poorer outcomes for the patient. Clinically this impacts not only the patient but also the healthcare setting in a number of ways.

Patient impact

  • Lower quality of life8
  • Increased risk of treatment interruption or delay9
  • Decreased survival9-11
  • Decreased physical function12

Healthcare setting impact

  • Extended hospital stays13,14
  • Increased risk of hospital re-admissions13,14
  • Increased costs of hospitalisation13,14
  • Increased post surgery complications15

Importance of good nutrition in cancer patients

Managing Malnutrition in Oncology

Identification of Malnutrition

Identification of malnutrition through screening is imperative, as recognised by the National Institute for Health and Care Excellence (NICE)16 and the European Society for Clinical Nutrition and Metabolism (ESPEN).5,17 Screening should be performed at the time of diagnosis.

Screening for malnutrition using 'MUST'

Need help in screening your patients for malnutrition? Nutricia are developing a free e-learning to support your knowledge of screening and managing malnutrition. Find out more here

Early nutritional intervention is key to support patient outcomes

 

Benefit of nutritional intervention on several quality of life aspects during treatment.18

Up to 50% reduction in post-operative complications after pre-operative ONS intervention.19,20

Up to a 3-day reduction in length of hospital stay.20

20% increase in probability of survival following early nutritional intervention and weight gain in some cancer patients.21

Oral Nutritional Supplements can play a role in a Cancer Patients Journey

ESPEN (2016)and ESPEN (2021)17 highlight the role that nutritional intevention plays in Oncology patients.

“Nutritional interventions are recommended to increase oral intake in cancer patients who are able to eat but are malnourished or at risk of malnutrition. This includes dietary advice, the treatment of symptoms and derangements impairing food intake (nutrition impact symptoms), and offering oral nutritional supplements.”

Oral nutritional supplements in Oncology

The causes of reduced nutritional intake are complex and multifactorial.5 Two prevelant causes of malnutrition in oncology patients are taste disturbance and poor appetite:

Taste and smell alterations may develop throughout the course of the disease, before, during and up to one year after treatment.5 Taste alterations could lead to a reduced intake of food and therefore have a negative impact on the nutritional status with up to 25% reduction in nutritional intake, leading to greater weight loss.22,23

Importance of sensory alterations for cancer patients with taste alteration

The Journal of Supportive Care in Cancer published a new study, showing that taste and smell alterations are common in patients receiving systemic antitumor therapy and that nutritional support specifically designed to better address sensory alterations, is appreciated in these patients.

 

Fortisip Compact Protein - innovative taste sensations

The Fortisip Compact Protein range has been developed with a wide range of flavours, providing a flavour variety to your patients can help prevent taste fatigue.24 A high energy,  high protein, low volume ONS with specific warming and cooling sensations appreciated in patients with Cancer.* Addressing the needs of taste alterations in cancer through creating sensations could help with compliance. 

Low volume ONS may make it easier to consume the energy levels needed25, 26, particularly with reported side effects in oncology patients. Compliance with low volume 125ml ONS is significantly better than standard ONS.25,26

Compliance with ONS

Adapted from Hubbard et al. 201226

 

Fortisip Compact Protein - high energy, high protein, low volume

Fortisip Compact Protein has been developed, offering a high energy, high protein, low volume ONS with 90% compliance.27

Read more about Fortisip Compact Protein

Find out more about how high energy, high protein, low volume Oral Nutritional Supplements deliver clinical and economic outcomes.²⁸

Screening for Malnutrition

Further support on screening for Malnutrition, including our Screening for Malnutrition e-learning

Nutritional intervention in Oncology patients

Our 'Good Days and Bad Days' video was developed highlight the importance of good nutrition in Cancer patients.

Resources

A range of Case Studies, Articles and further reading to support Nutrition in Oncology

Oncology e-Learning

This E-learning module is designed to support and improve your knowledge of managing Malnutrition in Oncology, as well as to provide guidance on the use of Oral Nutritional Supplements (ONS) for patients with cancer.

Nutrition in Oncology Webinar

This webinar showcases a multi-disciplinary approach to nutritional management in Oncology. Together, Emma, a Specialist Dietitian, and Judith, a Specialist Nurse, highlight the prevalence of malnutrition in Oncology and the important role nutrition plays.

British Journal of Nursing - Nutrition and Oncology

British Journal of Nursing article written by Emma Atkinson, Mcmillan Dietitian and Judith Atkinson, Specialist Nurse. Nutrition and Oncology: best practice and the development of a traffic light system.

Do you have a question?

Contact our team of experts for guidance on the use and composition of our product range, for support with queries regarding your Nutricia account and sampling service or to get in touch with your local Nutricia representative. We are available Monday to Thursday 9am-5pm and Friday 9am-4pm (except Bank Holidays)

  1. Arends, et al. Clin Nutr. 2017;36(5):1187-1196.
  2. DeWys WD et al. 1980; 69: 491-497.
  3. Stratton RJ et al. 2003.
  4. Ravosco, et al. J Clin Med. 2019; 8:1211.
  5. Arends et al. Clin Nutr. 2016;36(1):11-48
  6. Marín Caro et al. Clin Nutr. 2007;26(3):289-301
  7. Fearon, et al. Lancet Oncol. 2011;12(5):489-495.
  8. Sánchez-Lara, al. Nutr Cancer. 2012;64(4):526-534
  9. Ross et al. Br J Cancer. 2004;90(10):1905-1911.
  10. Martin et al. J Clin Oncol. 2015;33(1):90-99.
  11. Gannavarapu et al. J Oncol Pract. 2018;14(4):e238-e250
  12. Mariani et al. Support Care Cancer. 2012;20(2):301-309
  13. Planas et al. Support Care Cancer. 2016;24(1):429-435.
  14. Gourin et al. Ann Otol Rhinol Laryngol. 2014;123(2):101-110.
  15. Yu et al. Eur J Clin Nutr. 2013;67(7):732-737
  16. NICE. Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition. Clinical Guideline CG32. https://www.nice.org.uk/Guidance/CG32 [Accessed October 2020].
  17. Muscaritoli, Arends, Bachmann et al. Clin Nutr. 2021; 40: 2898-2913
  18. Baldwin et al. J Natl Cancer Inst. 2012, 104(5): 371-385
  19. Kabata et al. Support Care Cancer. 2015; 23: 365-370.
  20. Maňásek et al. Klin Onkol. 2016; 29: 351-357.
  21. Trestini et al. Eur J Clin Nutr. 2018;72:772-779
  22. Spotten et al. Ann Oncol. 2017;28(5):969-984.
  23. Brisbois et al. J Pain Symptom Manage. 2011;41(4):673-683.
  24. Ravasco. Eur J Oncol Nurs. 2005;9 Suppl 2:S84-91.
  25. Hubbard et al. Prov Nutr Soc. 2010;69E164
  26. Hubbard GP et al. Clin Nutr. 2012;31(3):293-312.
  27. Brown et al. Journal of Nutrition, Health and Ageing. 2020;24:305–11.
  28. Cawood et al. Ageing Res. Rev 2012;11(2):278-96 

 

*de Haan et al. Support Care Cancer. 2021. . https://doi.org/10.1007/s00520-021-06049-4

Fortisip Compact Protein is a Food for Special Medical Purposes for the dietary management of disease related malnutrition and must be used under medical supervision.

You may also be interested in

Nutricia uses cookies on this website. With your consent we will use them to measure and analyze usage of the website (analytical cookies), to tailor it to your interests (personalisational cookies), and to present you relevant advertising and information (targeting cookies). For more information please read the cookie policy.

Privacy Settings

You can choose your preferences anytime for cookies and tracking. For more information please read our cookie policy.

  • Strictly necessary

    They are necessary for the website to function and cannot be switched off. They are usually only set in response to actions made by you which amount to a request for services (setting your privacy preferences, logging in, filling in forms, etc.). You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.

  • Analytical cookies

    They allow us to count visits and traffic sources, to measure and improve the performance of our site. They show us which pages are the most and least popular and how visitors move around the site. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

  • Personalisation cookies

    They enable website’s enhanced functionality and personalisation. They may be set by us or by third parties whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

  • Targeting cookies

    They may be set through our site by our advertising partners, to build a profile of your interests and to show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.